Login / Signup

Immunogenomic classification of hepatocellular carcinoma patients for immune check-point inhibitors therapy: cui bono ?

Fasiha KanwalMatias A Avila
Published in: Gut (2022)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • machine learning
  • deep learning
  • prognostic factors
  • patient reported outcomes
  • replacement therapy